A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. - Wikidata - awgldk - TriplyDB

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

http://www.wikidata.org/entity/Q37038621

about

ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.Insufficient antibody validation challenges oestrogen receptor beta research.Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer.Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients.Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.ERβ expression and breast cancer risk prediction for women with atypias.Estrogen receptors and human disease: an update.Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs Estrogen receptor-positive breast cancer: a multidisciplinary challenge.Triple-negative breast cancer: investigating potential molecular therapeutic target.Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis.N-Methyl-N-nitrosourea as a mammary carcinogenic agent.Inhibitory effects of ERβ on proliferation, invasion, and tumor formation of MCF-7 breast cancer cells--prognostication for the use of ERβ-selective therapy.Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.Expression of oestrogen receptor beta isoforms is regulated by transcriptional and post-transcriptional mechanisms.Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†.The evolving role of oestrogen receptor beta in clinical breast cancer.Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EB Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.Evaluation of ER-α, ER-Β1 and ER-Β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers.Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers.Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.Estrogen receptor-beta is a potential target for triple negative breast cancer treatment

P2860

Q33739387-8AEC34EA-71C5-459D-9069-7E0E69B4E71B Q33866151-73A00C97-38C2-446E-A15A-2310DB9DB177 Q33885342-AB0FE924-DE6E-42E8-BB9F-5903D74377FF Q34086835-B511D13A-6A0E-41D2-8DE9-6EC0BAFF7756 Q34113589-20BEA257-2AF5-49F1-B3AC-4CEF8DC61181 Q34119028-DB259EFF-8E2E-40C8-9387-B7EB39E32295 Q34284302-45AF2C0F-18AE-44C6-8595-399D28268A3F Q34334131-3F68816D-677F-446F-A531-67276F87A0F0 Q34577709-0D0244FE-8AC7-49A2-8251-6F001916FA9F Q34663257-A1602143-D4B1-4B9B-A99F-389D05E90FB9 Q35271188-3E8F4C70-AEF2-40A7-A9D9-A2DDF4562793 Q35821415-F371D6A3-94D9-4375-823E-FE62D4BFDF26 Q35931634-8A3EE06E-B512-4AE0-A00F-5790E7390DF5 Q36248899-B4ED9BB5-5965-4F6E-B90E-503EACA0F5BE Q36661810-6CD65E35-1145-4873-9F30-1DDBFC33F79F Q36962972-A9E307DD-492F-4D13-A5DE-A88C06C8B539 Q37049590-F0B9DBDD-9CC5-4374-97A9-B42C8818F64E Q37624907-C1C481B9-3117-48D6-8BC1-36A15B70B3B5 Q37687422-3766633E-C437-44F4-98BC-83B18EB95FF6 Q37838375-40831BAB-F305-43DF-9DA6-7405BCB0A1E0 Q38259322-56E028F3-8083-48D5-9CDE-7350E9703B67 Q38572516-B7AE341A-1C5E-44A2-B421-DD70B0F264D1 Q38589651-F4195C0E-D362-4250-A490-1C5E7431D452 Q39367554-BE93CEDC-7ECC-413F-8E41-F98B2D02FFE5 Q39414774-09F22E2A-DB9E-46A8-8E7E-1962265DE6B3 Q39704713-F0031BE0-0851-43EE-878B-E461161F6D1D Q40773847-32AE7AE1-6207-4BC6-95C0-56A3B145041C Q41674321-6CBD9F5A-047C-4F93-8F0C-D250FDEAD6E0 Q41721517-9FACF7B2-8EE4-497F-8421-3AA96F88AB90 Q43212160-48BADF8E-950D-47DD-B149-7DA2F14A80C2 Q43738086-3101A158-DE1A-4D0A-AC98-2CA72E003F2B Q44380247-8AFA75E3-9466-4B4F-A5CD-3005F289F2F7 Q47394260-E7CECE4A-77EF-481C-AACB-AE913D6E5D44 Q51412868-BE5D73EE-0C6B-48F3-B549-ACB86F21112A Q52588451-C6A9598A-E8BC-434D-A340-0520514CC2E5 Q54672869-EC35DE23-1D51-427C-A846-E21833770D57 Q55300491-97FB898B-2E92-4F5D-9B95-141A3706852E Q58553027-B7EC890E-D7F2-4BE2-B565-5E966110407E

P2860

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

http://www.wikidata.org/entity/Q37038621

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A divergent role for estrogen ...... servational prospective study.

@en

A divergent role for estrogen ...... servational prospective study.

@nl

type

label

A divergent role for estrogen ...... servational prospective study.

@en

A divergent role for estrogen ...... servational prospective study.

@nl

prefLabel

A divergent role for estrogen ...... servational prospective study.

@en

A divergent role for estrogen ...... servational prospective study.

@nl

P1433

Q37038621-AA2E6DA4-C097-4155-B2E5-3DF1FFC7A271

P1476

Q37038621-6B985C2A-A647-47A1-83E1-7F680E4E97E9

P2093

Q37038621-09685113-3582-443D-927D-4E5856263A57

Q37038621-593E3E43-7586-4B0D-A2E7-3F67A3762FC6

Q37038621-6F570DA6-5D05-49C4-87B8-FCD611874B62

Q37038621-799694B5-9D85-4EAF-8DEF-4310C44B9A06

Q37038621-84E783F3-0A38-4EA7-94C9-DA0C562F083D

Q37038621-987CB988-68E0-4D92-A5BC-C1344DAEB418

Q37038621-B9E73B61-16A5-4339-94B8-0603659D6E42

Q37038621-C04082A4-7BD3-4D8E-B7E7-E60C343C4E06

Q37038621-E2C5CF60-6D54-42A1-BF5B-E5BCA6107647

Q37038621-FEC8A9F3-3065-4777-AA8E-B383718824FF

P2860

Q37038621-22217231-96C3-4C64-8689-FA8E3429B951

Q37038621-298E36B2-2416-4E12-BF07-E3B381B174ED

Q37038621-3D0BDBB9-CE01-4B8E-A3A6-D4E42F584F57

Q37038621-43404793-1547-484E-AB3D-0C6281FC4F7F

Q37038621-653D058F-D784-43E7-B87C-247DE410E488

Q37038621-739E5479-577A-4C23-83C0-AAB74875164E

Q37038621-7A41AE0E-A877-48E3-822C-73FA7C86B965

Q37038621-82AFBAE3-8C51-48A6-B047-A354B5D53BF9

Q37038621-8A8DD188-187C-4178-BFCD-9AEAC17567EF

Q37038621-900A0184-26E9-4FFC-976F-310F39089149

P2888

Q37038621-B2C6635B-4B81-47EA-8AE9-9743D58415A6

P304

Q37038621-82F17761-86A8-42FB-AE5F-B8360D5337D2

P31

Q37038621-14766821-155A-491C-B6E0-02D30381EDF4

P356

Q37038621-59067401-CC09-47FB-9D8F-B2A34F1ECE79

P433

Q37038621-1E739F57-2319-4EAA-A8F3-515CBE34AE6A

P478

Q37038621-254CB4FE-1FF1-4A67-BA83-F8C4F9B243AA

P50

Q37038621-0C7B597B-0CCB-46A3-B302-FB03CA139524

Q37038621-1A2B5E91-141B-43D4-8E95-1E59FFB7B035

Q37038621-452863B8-DEF3-4BA9-8F58-0F753DA64735

Q37038621-89ECB52D-E527-46CB-8F7E-8C59CA60880B

P577

Q37038621-AD4C076E-46DC-4799-8E6D-F10997763918

P5875

Q37038621-BF119108-60F6-4DC7-9C10-050A08B160CC

P6179

Q37038621-0A4C5A10-BDE3-4C4C-A445-B3F0455A93B6

P698

Q37038621-D5547282-44A9-421D-8AEB-E1074405A1DC

P932

Q37038621-1DCFCC97-99C6-4DF7-AB62-4E955C7AFF39

P356

P1433

Breast Cancer Research

P1476

A divergent role for estrogen ...... servational prospective study.

@en

P2093

Alessandra Fabi

http://www.w3.org/2001/XMLSchema#string

Anna Di Benedetto

http://www.w3.org/2001/XMLSchema#string

Cecilia Nisticò

http://www.w3.org/2001/XMLSchema#string

Irene Venturo

http://www.w3.org/2001/XMLSchema#string

Letizia Perracchio

http://www.w3.org/2001/XMLSchema#string

Marcella Mottolese

http://www.w3.org/2001/XMLSchema#string

Michele Milella

http://www.w3.org/2001/XMLSchema#string

Pier Giorgio Natali

http://www.w3.org/2001/XMLSchema#string

Raffaele Perrone-Donnorso

http://www.w3.org/2001/XMLSchema#string

Simonetta Buglioni

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas

Cloning and characterization of human estrogen receptor beta isoforms

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Repeated observation of breast tumor subtypes in independent gene expression data sets

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

Clinical value of the wild-type estrogen receptor beta expression in breast cancer.

Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity.

Steroid receptors in human breast tumorigenesis and breast cancer progression.

Classification and regression tree analysis in public health: methodological review and comparison with logistic regression.

The role of estrogen in the initiation of breast cancer

P2888

P304

R74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2139

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Marcella Mottolese

Isabella Sperduti

P577

2008-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23237704

http://www.w3.org/2001/XMLSchema#string

P6179

1034078142

http://www.w3.org/2001/XMLSchema#string

P698

18771580

http://www.w3.org/2001/XMLSchema#string

P932

2614505

http://www.w3.org/2001/XMLSchema#string